Home Phototherapy for Term Newborns With Icterus

NCT ID: NCT03536078

Last Updated: 2021-03-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

147 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-06-30

Study Completion Date

2019-06-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is designed as a randomised controlled multicenter study.The primary aim is to investigate if home phototherapy improves parent-child bonding compared to if treatment is performed at the hospital. The investigators will also istudy how home phototherapy is perceived by the parents, impact on breastfeeding and parents stress levels, if the method can be implemented etc.

Patients are included at 5 hospitals in Sweden. The plan is to include 250 term newborns with neonatal icterus at a level that needs phototherapy treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background: Almost half of all newborns develops jaundice, due to elevated levels of bilirubin. If levels are high phototherapy is needed to reduce the levels of bilirubin. Presently most children with neonatal jaundice in Sweden receives phototherapy admitted to hospital. There is fiberoptic equipment available that can be used at home to treat the newborns.

Aim: Primary aim is to investigate if parent-child bonding is improved with home phototherapy compared to phototherapy performed at the hospital.

Method:The study is designed as a randomised controlled multicenter study. Eligible parents and newborns are randomised to either treatment at home or at the hospital. Demographic data about the newborn such as for example apgar score, gender, time of birth etc are registered. At time of discharge parents answers questionnaires such as for example the Postpartum Bonding Questionnaire (PBQ), the Edinburgh Postnatal Depression Scale (EDPS), the Swedish Parenthood Stress Questionnaire etc. Parents experiences from home phototherapy will also be investigated through semistructured interviews.

Parents will asked to answer questionnaires at the time of discharge as well as at 4-months after discharge.

Analysis of data will be performed by using conventional parametric and non-parametric statistical methods.

The results of the study will be reported as scientific articles and as part of a thesis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neonatal Hyperbilirubinemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators
Group allocation blinded to the investigator.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Phototherapy at hospital

Newborns with icterus that receive treatment while being admitted to hospital.

Group Type NO_INTERVENTION

No interventions assigned to this group

Home phototherapy

Newborns with icterus receiving phototherapy at home.

Group Type EXPERIMENTAL

home phototherapy

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

home phototherapy

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Gestational age w36-42.
* Age of newborn 48 hours or more.
* Level of bilirubin 300-400 µmol/l

Exclusion Criteria

* Immunisation. Bilirubin \>400 µmol/l. Asphyxia. Ongoing infection, weightloss \> 10%, other severe disease, parents who don´t speak Swedish, parents that are not expected to be able to handle the home phototherapy equipment
Minimum Eligible Age

48 Hours

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Region Örebro County

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mats Eriksson, Professor

Role: PRINCIPAL_INVESTIGATOR

Örebro university, Region Orebro County

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Childrens department University hospital in Örebro

Örebro, Region Orebro County, Sweden

Site Status

Childrens department at Mälarsjukhuset/hospital

Eskilstuna, , Sweden

Site Status

Childrens department Falun hospital

Falun, , Sweden

Site Status

Childrens department Halmstad hospital

Halmstad, , Sweden

Site Status

Childrens department Karlstad hospital

Karlstad, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

References

Explore related publications, articles, or registry entries linked to this study.

Pettersson M, Ryen L, Eriksson M, Ohlin A. The cost-effectiveness of home phototherapy for hyperbilirubinemia in neonates: results from a randomized controlled trial. Sci Rep. 2023 Jul 3;13(1):10727. doi: 10.1038/s41598-023-37684-y.

Reference Type DERIVED
PMID: 37400561 (View on PubMed)

Pettersson M, Eriksson M, Blomberg K. Parental experiences of home phototherapy for neonatal hyperbilirubinemia. J Child Health Care. 2023 Dec;27(4):562-573. doi: 10.1177/13674935221082404. Epub 2022 Mar 26.

Reference Type DERIVED
PMID: 35341337 (View on PubMed)

Pettersson M, Eriksson M, Albinsson E, Ohlin A. Home phototherapy for hyperbilirubinemia in term neonates-an unblinded multicentre randomized controlled trial. Eur J Pediatr. 2021 May;180(5):1603-1610. doi: 10.1007/s00431-021-03932-4. Epub 2021 Jan 19.

Reference Type DERIVED
PMID: 33469713 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

209715

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.